Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis

Summary

The primary objective is to assess the activity of nerispirdine in improving the ability to walk, in patients with multiple sclerosis (MS). Secondary objectives: * To assess other measures of walking ability, tiredness, and lower limb muscular strength, spasticity, clinical assessment by subject and clinical assessment of change by the Study Investigator * To assess the safety and tolerance of nerispirdine * To evaluate the pharmacokinetics (PK) parameters of nerispirdine

Timeline

Start

2008-12

Primary completion

2010-03

Completion

2010-03

Drugs

Indications